Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer

By                        

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1051-1058

Spandidos Publications

Access to resources Recommend Favorite

Identification of EGFRvIII-derived CTL Epitopes Restricted by HLA A0201 for Dendritic Cell Based Immunotherapy of Gliomas

By Wu An-hua   Xiao Jing   Anker Lars   Hall Walter   Gregerson Dale   Cavenee Webster   Chen Wei   Low Walter  

Journal of Neuro-Oncology, Vol. 76, Iss. 1, 2006-01 ,pp. : 23-30

Springer Publishing Company

Access to resources Recommend Favorite

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

By Wobser Marion   Keikavoussi Petra   Kunzmann Volker   Weininger Markus   Andersen Mads   Becker Juergen  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 10, 2006-10 ,pp. : 1294-1298

Springer Publishing Company

Access to resources Recommend Favorite

Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope

By Thorn Mette   Wang Mingjun   Kløverpris Henrik   Schmidt Esben   Fomsgaard Anders   Wenandy Lynn   Berntsen Annika   Brunak Søren   Buus Søren   Claesson Mogens  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 11, 2007-11 ,pp. : 1755-1763

Springer Publishing Company

Access to resources Recommend Favorite

Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2⁺ patients with hormone-refractory prostate cancer

By Matsueda Satoko   Kobayashi Kazuhiko   Nonaka Yoichi   Noguchi Masanori   Itoh Kyogo   Harada Mamoru  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 6, 2004-06 ,pp. : 479-489

Springer Publishing Company

Access to resources Recommend Favorite